Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.3000 (-3.36%) ($26.7000 - $27.6000) on Sat. Nov. 5, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.91% (three month average) | RSI | 30 | Latest Price | $27.3000(-3.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -8.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -1.955% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.955% (StdDev 3.91%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
1 - 5 Day Possible Target | $15.78(-42.2%) | Resistance Level | $31.91 | 5 Day Moving Average | $28.25(-3.36%) | 10 Day Moving Average | $30.16(-9.48%) | 20 Day Moving Average | $31.91(-14.45%) | To recent high | -33.3% | To recent low | 0% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |